38 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
These 17 Words From AbbVie's CEO Explain Why the Stock Is Still a Buy https://www.fool.com/investing/2024/02/11/these-17-words-from-abbvies-ceo-explain-why-the-st/?source=iedfolrf0000001 Feb 11, 2024 - The drugmaker is handling its biggest obstacle yet relatively well.
2 Magnificent Dividend Growth Stocks to Load Up On Right Now https://www.fool.com/investing/2024/02/06/2-magnificent-dividend-growth-stocks-to-load-up-on/?source=iedfolrf0000001 Feb 06, 2024 - These two dividend-growth stocks are fantastic buys.
7 Dividend Stocks That Pay Me More Than $500 Per Month https://www.fool.com/investing/2024/02/03/7-dividend-stocks-that-pay-me-more-than-500-per-mo/?source=iedfolrf0000001 Feb 03, 2024 - These stocks pay safe, reliable, and growing dividends.
AbbVie (ABBV) Q4 2023 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/02/02/abbvie-abbv-q4-2023-earnings-call-transcript/?source=iedfolrf0000001 Feb 02, 2024 - ABBV earnings call for the period ending December 31, 2023.
AbbVie (ABBV) Q4 Earnings Beat, Raises Sales View for Key Drugs https://www.zacks.com/stock/news/2220511/abbvie-abbv-q4-earnings-beat-raises-sales-view-for-key-drugs?cid=CS-ZC-FT-analyst_blog|earnings_article-2220511 Feb 02, 2024 - AbbVie???s (ABBV) fourth-quarter earnings and sales beat estimates. Management hikes the 2027 forecast for new immunology drugs to more than $27 billion.
BLS Jobs Up Big: 353K, 3.7% Unemployment https://www.zacks.com/stock/news/2220369/bls-jobs-up-big-353k-3-7-unemployment?cid=CS-ZC-FT-ahead_of_wall_street-2220369 Feb 02, 2024 - 353K new jobs created for January are nearly double the 180K or so analysts were looking for.
AbbVie (ABBV) Reports Q4 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2220349/abbvie-abbv-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2220349 Feb 02, 2024 - The headline numbers for AbbVie (ABBV) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now https://www.fool.com/investing/2024/01/28/2-high-yield-healthcare-stocks-to-buy-with-both-ha/?source=iedfolrf0000001 Jan 28, 2024 - All three of these stocks offer attractive dividend yields, but one looks risky.
Gilead (GILD) Down as NSCLC Study Fails to Meet Primary Goal https://www.zacks.com/stock/news/2214367/gilead-gild-down-as-nsclc-study-fails-to-meet-primary-goal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2214367 Jan 23, 2024 - Gilead Sciences' (GILD) phase III study evaluating Trodelvy (sacituzumab govitecan) in previously treated metastatic NSCLC fails to meet its primary endpoint. Shares decline on the same.
Q4 Earnings Season Scorecard and Analyst Reports for Apple, AbbVie & Toyota https://www.zacks.com/commentary/2210770/q4-earnings-season-scorecard-and-analyst-reports-for-apple-abbvie-toyota?cid=CS-ZC-FT-research_daily-2210770 Jan 16, 2024 - Today's Research Daily features a real-time update on the Q4 earnings season and new research reports on Apple (AAPL), AbbVie (ABBV), Toyota Motor (TM) and others.

Pages: 1234

<Page 2>